Search is Powered by Google
Breast Cancer News

UK Search For Thousands Of Volunteers To Help Bring Cure For Breast Cancer Closer

Main Category: Breast Cancer
Article Date: 22 Apr 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Researchers, who are in the process of developing a blood test that may diagnose breast cancer up to four years earlier than a mammogram, need the help of thousands of people living in the East Midlands.

The University of Nottingham spin-out company Oncimmune pioneers anti-cancer technology, and has reached the final stages of its research which could identify an immune response to breast cancer.

The initial research came out of the laboratories of cancer specialist, John Robertson, Professor of Surgery at The University of Nottingham. If this test can be developed it will be the first of its kind in the world and it could be on trial in America this year.

Professor Robertson and his team need at least 3,500 healthy people to come forward and donate a blood sample which would be used both for further research and to help develop the technology. The researchers emphasise that there will not be any feedback of results to the donor.

Professor Robertson said: "We are getting close to having a blood test that will provide a better chance of identifying more people who have an early stage breast cancer at a point when it can be cured."

This huge blood collection project begins in earnest this month with a team of medical and support staff initially using health centres in their search for volunteers aged anywhere between 18 and 90 - to cover all decades of life. The team is also planning to take to the road travelling, by bus, to supermarkets, town centre markets, farmer's markets, health centres and libraries.

The search for donors starts in Nottinghamshire and move to Derbyshire and Leicestershire over the coming months.

Oncimmune's tests for cancer measure auto-antibodies that accumulate in the blood in reaction to the presence of a cancerous tumour, even when the tumour is in its earliest stages. Preliminary studies have already shown that the test can be positive up to four years earlier than a mammogram might indicate a breast cancer.

A £150,000 donation from Nottingham University Hospitals Charity has helped Professor Robertson's academic research department buy state of the art robot equipment to speed up part of the testing process. Some of the money was raised through the auction of an abstract work of art by Jennie Bambury which featured breast imprints of Nottinghamshire celebrities.

Most families have been affected by cancer and the best way to cure cancer is to detect it before it spreads. The difficulty is that a number of cancers, such as breast, colorectal, prostate and ovarian cancer, will have spread in the majority of patients before they are diagnosed.

Research into the detection of the immune response to breast and other types of cancer continues in Professor Robertson's laboratories at The University of Nottingham while the development of commercial products is funded through Oncimmune, Ltd.

In November last year Oncimmune announced the company was to open a North American arm in a 30 million dollar deal that also involved collaboration with cancer researchers at the University of Kansas.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The University of Nottingham is ranked in the UK's Top 10 and the World's Top 70 universities by the Shanghai Jiao Tong (SJTU) and Times Higher (THES) World University Rankings.

It provides innovative and top quality teaching, undertakes world-changing research, and attracts talented staff and students from 150 nations. Described by The Times as Britain's "only truly global university", it has invested continuously in award-winning campuses in the United Kingdom, China and Malaysia.

Twice since 2003 its research and teaching academics have won Nobel Prizes. The University has won the Queen's Award for Enterprise in both 2006 (International Trade) and 2007 (Innovation-School of Pharmacy).

Its students are much in demand from 'blue-chip' employers. Winners of Students in Free Enterprise for three years in succession, and current holder of UK Graduate of the Year, they are accomplished artists, scientists, engineers, entrepreneurs, innovators and fundraisers. Nottingham graduates consistently excel in business, the media, the arts and sport. Undergraduate and postgraduate degree completion rates are amongst the highest in the United Kingdom.

Source: Professor John Robertson
University of Nottingham


Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

Breast Cancer Treatment: Get Involved image Breast Cancer Treatment: Get Involved

Today, breast cancer patients may be treated by a multidisciplinary team of specialists, consisting of nurses, oncologists, surgeons, social workers, nutritionists and genetic counselors. However, patients, too, have a critical role in their treatment...

View more videos...